Postsurgical Glenohumeral Arthritis in Young Adults
- 9 June 2009
- journal article
- research article
- Published by SAGE Publications in The American Journal of Sports Medicine
- Vol. 37 (9), 1784-1791
- https://doi.org/10.1177/0363546509333481
Abstract
Background Chondrolysis has been reported as a sequela of arthroscopic shoulder surgery. Although the causes have yet to be fully elucidated, basic science and clinical evidence suggest a multifactorial origin. Surgical treatment in young patients with glenohumeral chondrolysis is particularly challenging, with little outcome data. Hypothesis Glenohumeral chondrolysis has several causes and patterns of presentation. Biological resurfacing is a viable treatment option for symptomatic glenohumeral arthritis. Study Design Case series; Level of evidence, 4. Methods Twenty patients (mean age, 19.7 years; range, 13.1-33.8) were referred for management of extensive glenohumeral arthritis after arthroscopy glenohumeral surgery (mean time postoperatively, 26 months; range, 3-73). Sixteen patients had an intra-articular pain pump placed for 2 to 3 days; 2 patients demonstrated prominent implants; and 2 had thermal treatment. Patients underwent revision surgery, including 7 biological resurfacings of the glenoid and humeral head, 4 biological resurfacings of the humeral head alone, and 7 other procedures. Eight patients having biological resurfacing were assessed just before the revision surgery, at a mean time of 3.1 years after revision (range, 1.9-6.5), with the American Shoulder and Elbow Surgeon scale and Simple Shoulder Test, Short Form 12 (physical and mental components), and visual analog scale score for pain. Results Patient outcomes scores improved from 51 to 71 (American Shoulder and Elbow Surgeon scale, P < .01), 7 to 10 (Simple Shoulder Test, P < .02), and 5 to 3 (visual analog scale, P < .01). Preoperative range of motion demonstrated modest improvements from 119° to 132° of flexion, 42° to 41° of external rotation, and internal rotation from L2 to T12 level. Two patients required an additional surgery: 1 total shoulder arthroplasty and 1 capsular release with debridement. Conclusion Severe glenohumeral arthritis is a devastating postoperative complication of glenohumeral arthroscopy. Although not a universal finding, the use of glenohumeral pain pumps is a concern, as well as suboptimal anchor placement. Biological resurfacing permits modest functional improvement in a challenging shoulder condition.Keywords
This publication has 27 references indexed in Scilit:
- Intra-articular pain pump catheter breakage after arthroscopic shoulder surgery: A case seriesJournal of Shoulder and Elbow Surgery, 2007
- Postarthroscopic Glenohumeral ChondrolysisThe American Journal of Sports Medicine, 2007
- Nonarthroplasty alternatives for the treatment of glenohumeral arthritisJournal of Shoulder and Elbow Surgery, 2007
- Effect of lateral meniscus allograft on shoulder articular contact areas and pressuresJournal of Shoulder and Elbow Surgery, 2007
- Chondrolysis After Continuous Intra-Articular Bupivacaine Infusion: An Experimental Model Investigating Chondrotoxicity in the Rabbit ShoulderArthroscopy: The Journal of Arthroscopic & Related Surgery, 2006
- In Vitro Exposure to 0.5% Bupivacaine Is Cytotoxic to Bovine Articular ChondrocytesArthroscopy: The Journal of Arthroscopic & Related Surgery, 2006
- Chondrolysis of the glenohumeral joint following arthroscopic capsular release for adhesive capsu litis: a case reportKnee Surgery, Sports Traumatology, Arthroscopy, 2006
- Glenohumeral Arthrosis in Anterior Instability before and after Surgical TreatmentThe American Journal of Sports Medicine, 2004
- Non-prosthetic management of grade IV osteochondral lesions of the glenohumeral jointJournal of Shoulder and Elbow Surgery, 2002
- Biologic resurfacing of the glenoid with hemiarthroplasty of the shoulderJournal of Shoulder and Elbow Surgery, 1995